A multicenter, randomized, double-blind, parallel-group, placebo-controlled, active-controlled study of the efficacy and safety of sustained-release quetiapine (Seqoquel) compared with placebo in the treatment of generalized anxiety disorder

Trial Profile

A multicenter, randomized, double-blind, parallel-group, placebo-controlled, active-controlled study of the efficacy and safety of sustained-release quetiapine (Seqoquel) compared with placebo in the treatment of generalized anxiety disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2011

At a glance

  • Drugs Escitalopram; Quetiapine
  • Indications Generalised anxiety disorder
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms GOLD
  • Sponsors AstraZeneca
  • Most Recent Events

    • 06 Dec 2011 Results from a pooled analysis published in the Human Psychopharmacology: Clinical and Experimental.
    • 28 Jun 2009 Planned pooled analysis of data from the GOLD, SILVER and TITANIUM trials presented at the 9th World Congress of Biological Psychiatry.
    • 19 May 2009 Planned pooled analysis of data from the GOLD, SILVER and TITANIUM and PLATINUM trials presented at the 162nd Annual Meeting of the American Psychiatric Association (APA 2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top